Navigation Links
Cardio3 BioSciences Raises EUR13.7 Million in Series B Fundraising and Grant Funding
Date:1/19/2009

am Wijns, co-Director of the Cardiovascular Center Aalst, and Prof. Michal Tendera of the Silesian Heart Centre, Katowice, a past president of the European Society of Cardiology.

Dr. Desire Collen, Chairman and CEO of Life Science Research Partners, VZW said, "The investment that we have made in Cardio3 BioSciences reflects our desire to support companies with cutting edge technologies that have the potential to transform medical practice. Cardio3 BioSciences's experienced management team along with the proprietary technology from Mayo Clinic offers the appropriate mix of scientific, industrial and commercial expertise to bring this novel treatment for heart failure to patients. The active participation of a number of world leading cardiologists in the clinical development of C-Cure highlights the need for such an improved treatment for heart failure and was an important factor in our decision to invest."

Mr Peter Wilhelm, Managing Director of Wilhelm & co., a returning investor which has participated in all Cardio3 BioSciences financing rounds said: "As a non-biotech specialist investor, the decision of my group to invest in Cardio3 BioSciences since its inception was based on the assessment of the people driving the Company. We were not mistaken about their quality. The collaboration between Cardio3 Biosciences, the Department of Cardiology of the hospital in Aalst and Mayo Clinic has allowed for considerable advances in the treatment of heart failure."

Ms Marie Dominique Simonet, Vice-President and Minister of Higher Education, Scientific Research and International Relations of the Wallon Region commented, "The Walloon Region, confident in the prospects of this promising project, has supported the company from the very beginning through cash advances granted by DGO6. Cardio3 BioSciences's successes so far have encouraged us to continue support for this project but also to other innovative comp
'/>"/>

SOURCE Cardio3 BioSciences
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
2. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
3. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
4. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
5. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
6. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
7. Alacrity Biosciences Announces Positive Results from a Phase 2 Study of Its Dry Eye Treatment ALTY-0501
8. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
9. Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System
10. Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions
11. Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)...  Rigrodsky & Long, P.A.: , Do you, ... LCI )? , Did you purchase your shares before ... 2014, inclusive? , Did you lose money in your ... to discuss your rights? Rigrodsky & ... Timothy J. MacFall , announces that a complaint has been filed ...
(Date:8/28/2014)... NEW YORK , Aug. 28, 2014 /PRNewswire/ ... report is available in its catalogue: ... http://www.reportlinker.com/p02343464/North-America-Laparoscopes-Market-Outlook-to-2020.html North ... GlobalData,s new report, "North America Laparoscopes Market ... the North America Laparoscopes market. The report provides ...
(Date:8/28/2014)... N.J. , Aug. 28, 2014 /PRNewswire-iReach/ -- ... medical device space, is excited to announce they ... the VIEW Plating System and REDUCE Fracture Plating ... anatomic plates used to support multiple indications within ... packaged Lapidus, First Metatarsophalangeal (MTP), Calcaneal-Cuboid (CC), Talonavicular ...
Breaking Medicine Technology:Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 2Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 3North America Laparoscopes Market Outlook to 2020 2North America Laparoscopes Market Outlook to 2020 3North America Laparoscopes Market Outlook to 2020 4North America Laparoscopes Market Outlook to 2020 5North America Laparoscopes Market Outlook to 2020 6North America Laparoscopes Market Outlook to 2020 7North America Laparoscopes Market Outlook to 2020 8North America Laparoscopes Market Outlook to 2020 9North America Laparoscopes Market Outlook to 2020 10North America Laparoscopes Market Outlook to 2020 11EDGE Orthopaedics Receives Second FDA Clearance 2
... 2011 Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR ... candidate, has been granted orphan drug designation from the ... of pediatric Clostridium difficile infection (CDI).  This ... covers all formulations of fidaxomicin used to treat ...
... 2011 ULURU Inc. (NYSE Amex: ULU), ... a portfolio of wound management and oral care products, today ... 5,000,000 shares of its common stock at a price per ... an institutional investor, resulting in gross proceeds of approximately $500,000. ...
Cached Medicine Technology:Optimer Pharmaceuticals Receives Orphan Drug Designation for Fidaxomicin for the Treatment of Pediatric Clostridium difficile Infection 2Optimer Pharmaceuticals Receives Orphan Drug Designation for Fidaxomicin for the Treatment of Pediatric Clostridium difficile Infection 3Optimer Pharmaceuticals Receives Orphan Drug Designation for Fidaxomicin for the Treatment of Pediatric Clostridium difficile Infection 4ULURU Inc. to Raise $500,000 in Registered Direct Offering 2
(Date:8/28/2014)... HORNE LLP has laid out the ... The $67 million firm has more than feel-good emotions ... in the balance. , Described by experts in the ... of Baby Boomers creating succession issues, poor leadership development ... creating culture wars within firms that are threatening the ...
(Date:8/28/2014)... third of women who are given information about the ... may not fully understand the risks involved, according to ... (BJC) , today (Friday). , In a survey of ... College London (UCL) found that 64 per cent felt ... the chance that screening will pick up cancers that ...
(Date:8/28/2014)... Worth, FL (PRWEB) August 28, 2014 ... National Recovery Month throughout September. This month will ... addiction treatment and mental health services. Along with ... Treatment Group is helping to spread the word ... began in 1989, honoring the work of treatment ...
(Date:8/28/2014)... 2014 Millennium Treatment Group has noticed ... the workplace. A recent report from the National ... that drug abuse is costing employers an estimated $81 ... addicted to drugs affect their employers and the company ... the workplace, causing expensive problems for their employers, such ...
(Date:8/28/2014)... HealthDay Reporter THURSDAY, Aug. 28, ... may worsen symptoms of multiple sclerosis (MS), a new study ... as vitamin D, smoking and Epstein Barr virus infection. Our ... factor affecting MS patients," said lead researcher Dr. Mauricio Farez, ... Aires. Multiple sclerosis is a disease of the nervous ...
Breaking Medicine News(10 mins):Health News:HORNE LLP Proclaims War on Accounting Firm Culture 2Health News:Some women still don't underststand 'overdiagnosis' risk in breast screening 2Health News:Millennium Treatment Group Celebrates National Recovery Month 2Health News:Drug Use Causes Problems in the Workplace 2Health News:Could Too Much Salt Harm MS Patients? 2Health News:Could Too Much Salt Harm MS Patients? 3
... Reporter , THURSDAY, March 3 (HealthDay News) -- More young ... men are engaging in same-sex encounters, according to a new ... statistics compiled from interviews with 13,500 men and women aged ... also indicates that more than half of young people under ...
... will hold its 111th General Meeting May 21-24, ... will feature approximately 3,000 individual scientific presentations spanning ... attendance of 10,000. Microbiologists study living organisms ... to human and animal health, agriculture, the environment ...
... 3 (HealthDay News) -- The brain,s so-called reward center actually ... experiences causing fear, finds a new study in mice. ... may help explain why some people are thrill-seekers. Pleasurable ... off a bridge, can trigger the production of dopamine, a ...
... HealthDay Reporter , THURSDAY, March 3 (HealthDay News) -- A new ... a position thought to pose a risk for SIDS -- have ... on their backs. The discovery suggests that a lack of ... at a higher risk of sudden infant death syndrome while sleeping: ...
... Medicine have discovered that a natural product isolated from a ... or lei gong teng, and used for hundreds of years ... gene control machinery in the cell. The report, published as ... Chemical Biology, suggests that the natural product could be ...
... Unexpected results from a Scripps Research Institute and ModGene, ... to the liver instead of the brain as the source ... with this devastating condition. The findings could offer a relatively ... was published online today in The Journal of Neuroscience ...
Cached Medicine News:Health News:More Young People Delay Sex, Try Oral Sex First, CDC Says 2Health News:More Young People Delay Sex, Try Oral Sex First, CDC Says 3Health News:American Society for Microbiology to host 111th General Meeting in New Orleans 2Health News:Research Uncovers Clue to SIDS 2Health News:Solving a traditional Chinese medicine mystery 2Health News:Solving a traditional Chinese medicine mystery 3Health News:Scripps Research study points to liver, not brain, as origin of Alzheimer's plaques 2Health News:Scripps Research study points to liver, not brain, as origin of Alzheimer's plaques 3Health News:Scripps Research study points to liver, not brain, as origin of Alzheimer's plaques 4
PDA application containing all 7,000+ Physicians' Current Procedural Terminology codes developed by the American Medical Association....
PDA application contains 15,000+ ICD-9-CM Diagnosis codes....
Contains the most common procedures from all orthopedic sub-specialties organized by body area....
Athouritative, on the spot answers for acute care and consultations....
Medicine Products: